Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Nuklearmedizin

Retrieve available abstracts of 96 articles:
HTML format
Text format



Single Articles


    July 2015
  1. RAGER O, Baskin A, Amzalag G, Buchegger F, et al
    Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  2. WEISS M, Schwarz F, Wallmichrath J, Baumeister R, et al
    Chylothorax and chylous ascites. Clinical utility of planar scintigraphy and tomographic imaging with SPECT/CT.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  3. PICCARDO A, Puntoni M, Morbelli S, Massollo M, et al
    18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  4. WUEST W, Lell M, May MS, Saake M, et al
    Thoracic non-osseous lesions in cancer patients detected in low-dose CT images acquired as part of skeletal SPECT/CT examinations.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    June 2015
  5. STEINHOFF KG, Hankir M, Krause K, Tonjes A, et al
    Interaction of thyroid hormone with brown adipose tissue. Lessons learned from PET-CT.
    Nuklearmedizin. 2015;54:82-7.
    PubMed     Text format     Abstract available


  6. FULARZ M, Adamiak P, Czepczynski R, Jarzabek-Bielecka G, et al
    Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    April 2015
  7. EZZIDDIN S, Khalaf F, Seidel M, Al Zreiqat A, et al
    Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy. A new tool to differentiate psoriatic from rheumatoid arthritis.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    February 2015
  8. LORENZ R, Buck A, Reiners C
    In-patient nuclear medicine therapy in Germany from 2010 to 2012. Analysis of structured quality reports.
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


  9. FIETHEN S, Schlieper G, Mottaghy FM, Heinzel A, et al
    [Detektion einer pleuro-peritonealen Leckage bei Peritonealdialyse mit Hilfe der Peritonealszintigraphie mit SPECT/CT].
    Nuklearmedizin. 2015;54:N4-5.
    PubMed     Text format    


  10. SCHREITER V, Steffen I, Huebner H, Bredow J, et al
    Ventilation/perfusion SPECT/CT in patients with pulmonary emphysema. Evaluation of software-based analysing.
    Nuklearmedizin. 2015;54:31-5.
    PubMed     Text format     Abstract available


  11. KOTZERKE J, Oehme L, Grosse J, Hellwig D, et al
    [Positron emission tomography 2013 in Germany. Results of the query and current status.]
    Nuklearmedizin. 2015;54.
    PubMed     Text format     Abstract available


    November 2014
  12. BRAEUNING U, Pfannenberg C, Gallwitz B, Teichmann R, et al
    11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.
    Nuklearmedizin. 2014;54.
    PubMed     Text format     Abstract available


  13. KALTENBACH TE, Graeter T, Mason RA, Kratzer W, et al
    Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue(R)) with quantified 18F-FDG-PET-CT.
    Nuklearmedizin. 2014;54.
    PubMed     Text format     Abstract available


    October 2014
  14. TSAI SC, Ou YC, Cheng CL, Li JR, et al
    Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.
    Nuklearmedizin. 2014;54.
    PubMed     Text format     Abstract available


  15. SZTURZ P, Prasek M, Rehak Z, Fabian P, et al
    Unicentric Castleman disease: from screening mammography to PET/CT imaging.
    Nuklearmedizin. 2014;53:N41-3.
    PubMed     Text format    


    September 2014
  16. KUPITZ D, Apostolova I, Lange C, Ulrich G, et al
    Global scaling for semi-quantitative analysis in FP-CIT SPECT.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    August 2014
  17. RAUSCH I, Bergmann H, Geist B, Schaffarich M, et al
    Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


  18. BLUM S, Pannach S, Brogsitter C, Abolmaali N, et al
    Acute diverticulitis is positive in 11C-acetate PET/CT.
    Nuklearmedizin. 2014;53:N33-4.
    PubMed     Text format    


  19. KRUSE V, Van de Wiele C, Borms M, Maes A, et al
    CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve.
    Nuklearmedizin. 2014;53:131-8.
    PubMed     Text format     Abstract available


  20. DUNZINGER A, Decker J, Kieberger A, Weis S, et al
    Unusual loss of FDG uptake in recurrent GIST.
    Nuklearmedizin. 2014;53:N35-7.
    PubMed     Text format    


  21. KIM HA, Yoon SH, Yoon JK, Lee SJ, et al
    Salivary gland scintigraphy in Sjogren's syndrome. Comparison of the diagnostic performance of visual and semiquantitative analysis.
    Nuklearmedizin. 2014;53:139-45.
    PubMed     Text format     Abstract available


    July 2014
  22. FREESMEYER M, Winkens T, Opfermann T, Elsner P, et al
    Real-time ultrasound and freehand-SPECT. Experiences with sentinel lymph node mapping.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


  23. TAUHARDT E, Reissig A, Winkens T, Freesmeyer M, et al
    Early detection of disease progression after palliative chemotherapy in NSCLC patients by 18F-FDG-PET.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    June 2014
  24. BRIX G, Nosske D, Lechel U
    Radiation exposure of patients undergoing whole-body FDG-PET/CT examinations. An update pursuant to the new ICRP recommendations.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    May 2014
  25. HEISS WD
    [PET in gliomas. Overview of current studies.]
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    April 2014
  26. AZIZI M, Bahrieniain SA, Baghdasarians A, Emamipur S, et al
    The role of cognitive group therapy and happiness training on cerebral blood flow using 99mTc-ECD brain perfusion SPECT. A quasi-experimental study of depressed patients.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


  27. USLU L, Asa S, Sager S, Halac M, et al
    Multiple cardiac masses and distant metastatic foci in a patient with high grade pleomorphic sarcoma of the heart revealed by follow-up FDG PET/CT.
    Nuklearmedizin. 2014;53:N8-9.
    PubMed     Text format    


  28. SABET A, Ahmadzadehfar H, Bruhman J, Sabet A, et al
    Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
    Nuklearmedizin. 2014;53:39-45.
    PubMed     Text format     Abstract available


  29. DUNET V, Maeder P, Nicod-Lalonde M, Lhermitte B, et al
    Combination of MRI and dynamic FET PET for initial glioma grading.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    March 2014
  30. FURST S, Souvatzoglou M, Martinez-Moller A, Schwaiger M, et al
    Impact of flexible body surface coil and patient table on PET quantification and image quality in integrated PET/MR.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    February 2014
  31. BERNSTEIN P, Beuthien-Baumann B, Kotzerke J, Hofheinz F, et al
    Periacetabular bone metabolism following hip revision surgery. PET-based evaluation of allograft osteointegration.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


  32. MAUS J, Hofheinz F, Schramm G, Oehme L, et al
    Evaluation of PET quantification accuracy in vivo. Comparison of measured FDG concentration in the bladder with urine samples.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


  33. SCHENKE S, Zimny M, Rink T, Stahl U, et al
    [99mTc-MIBI scintigraphy of hypofunctional thyroid nodules. Comparison of planar and SPECT imaging.]
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


    January 2014
  34. KARANTANIS D, Kalkanis D, Allen-Auerbach MS, Herrmann K, et al
    Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available


  35. HOEBEN BA, Troost EG, Bussink J, van Herpen CM, et al
    18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients.
    Nuklearmedizin. 2014;53.
    PubMed     Text format     Abstract available



  36. Proceedings and abstracts of the 52nd Annual Congress of the German Nuclear Medicine Society, March 26-29, 2014, Hanover, Germany.
    Nuklearmedizin. 2014;53:N3.
    PubMed     Text format    


  37. KOTZERKE J
    [Structured review].
    Nuklearmedizin. 2014;53:N3.
    PubMed     Text format    


  38. GIOVANELLA L, Treglia G, Ceriani L, Verburg F, et al
    Detectable thyroglobulin with negative imaging in differentiated thyroid cancer patients. What to do with negative anatomical imaging and radioiodine scan?
    Nuklearmedizin. 2014;53:1-10.
    PubMed     Text format     Abstract available


  39. LINDNER O, Burchert W, Schafers M, Schaefer W, et al
    [Myocardial perfusion scintigraphy 2012 in Germany. Results of the 6th Query].
    Nuklearmedizin. 2014;53:13-8.
    PubMed     Text format     Abstract available


  40. PAK K, Kim SJ, Kim IJ, Kim DU, et al
    Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma.
    Nuklearmedizin. 2014;53:26-31.
    PubMed     Text format     Abstract available


  41. PIRICH C, Keinrath P, Rettenbacher L, Rendl G, et al
    99mTc tetrofosmin myocardial perfusion scintigraphy in CAD. Performance with early and standard delayed acquisition and fractional flow reserve.
    Nuklearmedizin. 2014;53:111-6.
    PubMed     Text format     Abstract available


    December 2013
  42. METIVIER D, Montravers F, Balogova S, Talbot JN, et al
    18F-FDG PET/CT uptake due to poly-L-lactic acid facial injections.
    Nuklearmedizin. 2013;52:N66-7.
    PubMed     Text format    


  43. MUELLAUER J, Willimayer R, Goertzen AL, Wanek T, et al
    18F, 11C and 68Ga in small animal PET imaging. Evaluation of partial volume correction methods.
    Nuklearmedizin. 2013;52:250-61.
    PubMed     Text format     Abstract available


  44. BARES R, Brenner W, Kirsch CM
    [Bone scintigraphy. German Guideline S1].
    Nuklearmedizin. 2013;52:207-11.
    PubMed     Text format     Abstract available


    November 2013
  45. AN YS , Lee DH, Yoon JK, Lee SJ, et al
    Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    Nuklearmedizin. 2013;53.
    PubMed     Text format     Abstract available


    October 2013
  46. USLU L , Sen F, Sager S, Halac M, et al
    Extensive peritoneal and pleural lymphomatosis in a patient with Burkitt lymphoma revealed with 18F-FDG PET/CT.
    Nuklearmedizin. 2013;52:N56-N57.
    PubMed     Text format    


  47. KRANERT T , Menzel C, Bartenstein P, Brust P, et al
    [Perfusion brain imaging with SPECT-technique. German Guideline S1.]
    Nuklearmedizin. 2013;52:157-162.
    PubMed     Text format     Abstract available


  48. KARAPOLAT I , Sertpoyraz F, Oncel G, Kobak S, et al
    Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


    September 2013
  49. WEISS M , Landrock S, Wallmichrath J, Baumeister RG, et al
    [The clinical yield of SPECT/CT for the assessment of lymphatic transport disorders. First experiences.]
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


    August 2013
  50. WIEDER HA , Tekin G, Rosenbaum-Krumme S, Klode J, et al
    18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma.
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


  51. FURTH C , Erdrich AS, Steffen IG, Ruf J, et al
    Interim PET response criteria in paediatric non-Hodgkin's lymphoma. Results from a retrospective multicenter reading.
    Nuklearmedizin. 2013;52:148-56.
    PubMed     Text format     Abstract available


    June 2013
  52. STECKER FF , Schierz JH, Opfermann T, Driesch D, et al
    Early dynamic 18F-FDG PET/CT to diagnose chronic osteomyelitis following lower extremity fractures. A pilot study.
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


  53. TREGLIA G , Bertagna F, Sadeghi R, Verburg FA, et al
    Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk.
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


    May 2013
  54. CAOBELLI F , Pizzocaro C, Paghera B, Guerra UP, et al
    Evaluation of patients with coronary artery disease. IQ-SPECT protocol in myocardial perfusion imaging: Preliminary results.
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


  55. JEONG J , Cho I, Kong E, Chun K, et al
    Evaluation of hybrid PET/CT gastrography in gastric cancer.
    Nuklearmedizin. 2013;52:107-12.
    PubMed     Text format     Abstract available


  56. KONG E , Chun K, Hong Y, Hah J, et al
    18F-FDG PET/CT findings in patients with Kikuchi disease.
    Nuklearmedizin. 2013;52:101-6.
    PubMed     Text format     Abstract available


    March 2013
  57. MEYER GJ
    [Nuclear medicine entangled by administrative regulations].
    Nuklearmedizin. 2013;52:N11-5.
    PubMed     Text format     Abstract available


    January 2013
  58. VAN DE WIELE C , Stellamans K, Brugman E, Mees G, et al
    Quantitative pretreatment VOI analysis of liver metastases. 99m Tc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT.
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


  59. KNAUSL B , Rausch IF, Bergmann H, Dudczak R, et al
    Influence of PET reconstruction parameters on the TrueX algorithm. A combined phantom and patient study.
    Nuklearmedizin. 2013;52.
    PubMed     Text format     Abstract available


  60. DRESCHER R , Muller A, Lesser T, Freesmeyer M, et al
    PET/ultrasound fusion for differentiation of Vox implant silicone particles from recurrent cancer.
    Nuklearmedizin. 2013;52:N29-30.
    PubMed     Text format    


  61. MULLER WU
    [Agencies for radiation protection in Germany, Europe and worldwide. Responsibilities and relations between].
    Nuklearmedizin. 2013;52:N17-20.
    PubMed     Text format     Abstract available


  62. LINDNER O , Burchert W, Hacker M, Schaefer W, et al
    [Myocardial perfusion scintigraphy - short form of the German guideline].
    Nuklearmedizin. 2013;52:51-63.
    PubMed     Text format     Abstract available


  63. DIESSL S, Verburg F, Biko J, Schryen B, et al
    Improved follow-up of patients with differentiated thyroid carcinoma. The quantitative detection limit of 131I uptake in diagnostic scans.
    Nuklearmedizin. 2013;52:81-7.
    PubMed     Text format     Abstract available


    December 2012
  64. YI C , Wang X, Shi X, Zhang X, et al
    18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall.
    Nuklearmedizin. 2012;51:N53-4.
    PubMed     Text format    


    November 2012
  65. RIEMANN B , Uhrhan K, Dietlein M, Schmidt D, et al
    Diagnostic value and therapeutic impact of 18 F-FDG-PET/CT in differentiated thyroid cancer. Results of a German multicentre study.
    Nuklearmedizin. 2012;52.
    PubMed     Text format     Abstract available


    September 2012
  66. TEEUWEN PH , de Geus-Oei LF, Hendriks T, van Goor H, et al
    Hybrid 18F-FDG PET/CT of colonic anastomosis. A possibility to detect anastomotic leakage?
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


    August 2012
  67. UBL P , Ringhofer L, Dolliner P, Staudenherz A, et al
    [A retrospective referral analysis in nuclear medicine.]
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  68. ROSENBAUM-KRUMME S , Nagarajah J, Ruhlmann M, Bockisch A, et al
    124I-PET/CT images of differentiated thyroid cancer patients. Distinguishing lymph node metastases from thyroid remnants using kinetic quantities.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


    May 2012
  69. SEIFEN T , Rettenbacher L, Thaler C, Holzmannhofer J, et al
    Prolonged back pain attributed to suspected spondylodiscitis. The value of 18F-FDG PET/CT imaging in the diagnostic work-up of patients.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  70. LETOVANEC I , Allenbach G, Mihaescu A, Nicod Lalonde M, et al
    18F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


    April 2012
  71. KAHRAMAN D , Eggers C, Holstein A, Schneider C, et al
    123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  72. ADAM G , Forsting M, Bockisch A, Kotzerke J, et al
    [Building the future together].
    Nuklearmedizin. 2012;51:33-4.
    PubMed     Text format    


  73. WIEDER H , Freudenberg LS, Czernin J, Navar BN, et al
    Variations of clinical SPECT/CT operations. An international survey.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  74. THORWARTH D , Beyer T, Boellaard R, de Ruysscher D, et al
    Integration of FDG-PET/CT into external beam radiation therapy planning. Technical aspects and recommendations on methodological approaches.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  75. DOBRINDT O , Hoffmeyer B, Ruf J, Seidensticker M, et al
    MRI versus bone scintigraphy. Evaluation for diagnosis and grading of stress injuries.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


    March 2012
  76. SCHAEFER A , Nestle U, Kremp S, Hellwig D, et al
    Multi-centre calibration of an adaptive thresholding method for PET-based delineation of tumour volumes in radiotherapy planning of lung cancer.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  77. SABET A , Ezziddin S, Heinemann F, Guhlke S, et al
    Osseous metastases of gastro-enteropancreatic neuroendocrine tumours. Diagnostic value of intra-therapeutic 177Lu-octreotate imaging in comparison with bone scintigraphy.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  78. HELLWIG D , Freudenberg LS, Mottaghy FM, Franzius C, et al
    [Nuclear Medicine in Europe: Education. Die Ausbildungssituation.]
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


    February 2012
  79. NAGARAJAH J , Dannat T, Hartung V, Bockisch A, et al
    18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
    Nuklearmedizin. 2012;51.
    PubMed     Text format     Abstract available


  80. BIERSACK HJ , Wingenfeld C, Hinterthaner B, Frank D, et al
    [SPECT-CT of the foot].
    Nuklearmedizin. 2012;51:26-31.
    PubMed     Text format     Abstract available


  81. CICONE F , Del Forno M, Papa A, Comito F, et al
    Fatal pulmonary tumour thrombotic microangiopathy: Do typical FDG-PET findings exist?
    Nuklearmedizin. 2012;51:N6-9.
    PubMed     Text format    


  82. FREESMEYER M , Lopatta E, Schierz JH, Steenbeck J, et al
    Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR.
    Nuklearmedizin. 2012;51:N10-1.
    PubMed     Text format    


    January 2012
  83. WESTER HJ
    [GMP production.Shaping the future].
    Nuklearmedizin. 2012;51:N1-4.
    PubMed     Text format    


  84. KOTZERKE J , Luster M, Freesmeyer M
    [Give me a fixed point in space, and I will lift the world upside down].
    Nuklearmedizin. 2012;51:65-6.
    PubMed     Text format    


  85. ROSENBAUM-KRUMME SJ , Bockisch A, Nagarajah J
    Pioglitazone therapy in progressive differentiated thyroid carcinoma.
    Nuklearmedizin. 2012;51:111-5.
    PubMed     Text format     Abstract available


  86. KROHN T , Ghassemi A, Gerressen M, Verburg FA, et al
    Bone graft scintigraphy. A new diagnostic tool to assess perfusion during surgery.
    Nuklearmedizin. 2012;51:201-4.
    PubMed     Text format     Abstract available


    October 2011
  87. HOFHEINZ F , Potzsch C, Oehme L, Beuthien-Baumann B, et al
    Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets.
    Nuklearmedizin. 2011;51.
    PubMed     Text format     Abstract available


  88. BUCHEGGER F , Viertl D, Baechler S, Dunet V, et al
    68Ga-NODAGA-RGDyK for alphavbeta3 integrin PET imaging. Preclinical investigation and dosimetry.
    Nuklearmedizin. 2011;50.
    PubMed     Text format     Abstract available


    February 2011
  89. JONAS G , Oehme L, Burchert W
    [Inventory Resources of Nuclear Medicine.]
    Nuklearmedizin. 2011;51.
    PubMed     Text format     Abstract available


    January 2011
  90. GEIGER S , Horster S, Haug AR, Hausmann A, et al
    Suspected osseous recurrence visualized on a 68Ga-DOTATATE PET/CT scan during the follow-up of a patient with a resected pulmonary carcinoid tumour.
    Nuklearmedizin. 2011;50:N57-9.
    PubMed     Text format    


  91. BEHRENDT FF , Krohn T, Palmowski M, Mottaghy FM, et al
    18F-FDG-PET/CT in myelofibrosis.
    Nuklearmedizin. 2011;50:N66-7.
    PubMed     Text format    


  92. SABET A , Strunk H, Ahmadzadehfar H, Welz A, et al
    Bone erosion due to aortic prosthesis by 18F-FDG-PET/CT.
    Nuklearmedizin. 2011;50:N63.
    PubMed     Text format    


  93. FREUDENBERG LS
    [Everything is difficult before it becomes easy].
    Nuklearmedizin. 2011;50:N29-30.
    PubMed     Text format    


  94. DERON P , Mertens K, Goethals I, Rottey S, et al
    Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.
    Nuklearmedizin. 2011;50:141-6.
    PubMed     Text format     Abstract available


  95. LUSTER M , Simon D
    [From the lack of transferability of international guidelines for thyroid diagnosis].
    Nuklearmedizin. 2011;50:175-77.
    PubMed     Text format    


  96. GORGES R , Kandror T, Kuschnerus S, Zimny M, et al
    [Scintigraphically "hot" thyroid nodules mainly go hand in hand with a normal TSH].
    Nuklearmedizin. 2011;50:179-88.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: